Integrated Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System
NCT ID: NCT00904072
Last Updated: 2009-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50000 participants
OBSERVATIONAL
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of a Novel Computerized Physician Order Entry System
NCT00713297
Evaluations of CDS Systems
NCT06330740
Improving Safety and Quality With Outpatient Order Entry
NCT00243334
Improving Safety By Computerizing Outpatient Prescribing
NCT00235027
Improving Safety by Basic Computerizing Outpatient Prescribing
NCT01091038
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. To identify what kind of drugs are most likely to cause duplication use by the physicians, and what kind of drugs are most likely to exceed the maximum dosage, also to know what kind of drugs are most likely to cause drug-drug interaction that physicians encounter during prescribing.
3. To evaluate the percentage of physician acceptance of the prescribing errors identify by the CDSS.
4. What's the impact of CDSS on pharmacist announced prescribing error.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
accepted
The suggestions provided by the CDSS which were accepted by the physicians.
No interventions assigned to this group
denied
The suggestions provided by the CDSS which were denied by the physicians.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grauduate Institute of Clinical Pharmacy, College of medicine, National Taiwan university, Grauduate Institute of Clinical Pharmacy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fe-Lin Lin Wu, Associate Professor
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital Taipei, Taiwan
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20080306OR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.